<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The hMSH2(M688R) mismatch repair (MMR) gene mutation has been found in five large families from Tenerife, Spain, suggesting it is a <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> or hereditary non-<z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (LS/HNPCC) <z:e sem="disease" ids="C0263541" disease_type="Disease or Syndrome" abbrv="">founder</z:e> mutation </plain></SENT>
<SENT sid="1" pm="."><plain>In addition to classical LS/HNPCC <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, these families present with a high incidence of central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> normally associated with Turcot or constitutional mismatch repair deficiency (CMMR-D) syndromes </plain></SENT>
<SENT sid="2" pm="."><plain>Turcot and CMMR-D mutations may be biallelic, knocking out both copies of the MMR gene </plain></SENT>
<SENT sid="3" pm="."><plain>The hMSH2(M688R) mutation is located in the ATP hydrolysis (ATPase) domain </plain></SENT>
<SENT sid="4" pm="."><plain>We show that the hMSH2(M688R)-hMSH6 heterodimer binds to mismatched <z:chebi fb="9" ids="36976">nucleotides</z:chebi> but lacks <z:mpath ids='MPATH_458'>normal</z:mpath> ATP functions and inhibits MMR in vitro when mixed with the <z:mp ids='MP_0002169'>wild-type</z:mp> (WT) heterodimer </plain></SENT>
<SENT sid="5" pm="."><plain>Another alteration that has been associated with LS/HNPCC, hMSH2(M688I)-hMSH6, displays no identifiable differences with the WT heterodimer </plain></SENT>
<SENT sid="6" pm="."><plain>Interestingly, some extracolonic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> from hMSH2(M688R) carriers may express hMSH2-hMSH6, yet display microsatellite instability (MSI) </plain></SENT>
<SENT sid="7" pm="."><plain>The functional analysis along with variability in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> expression and the high incidence of <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> suggests that hMSH2(M688R) may act as a dominant negative in some tissues, while the hMSH2(M688I) is most likely a benign polymorphism </plain></SENT>
</text></document>